Author

Ignacio Marín-Jiménez 1

1 Gastroenterology,Hospital Gregorio Marañón,Madrid,Spain

Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish Microscopic Colitis Group

Fernando Fernández-Bañares, Maria José Casanova, Y. Arguedas, Belen Beltran, Juan Manuel Fernández Font, L Fernández-Salazar, E García-Planella, Danila Guagnozzi, Alfredo J. Lucendo, N. Manceñido, Ignacio Marín-Jiménez, Miquel Montoro, Marta Piqueras Cano, Virginia Robles, A. Ruiz-Cerulla, Javier Gisbert

CAN A PATIENT RATE THE ACTIVITY OF THEIR CROHN´S DISEASE THROUGH A MOBILE APP? THE MEDICROHN STUDY. 

Ana Echarri Piudo, Isabel Vera Mendoza, Jordi Guardiola Capon, Virginia Ollero, Beatriz Castro, Francisco Gallego, Mariam Aguas, Maria Chaparro Sanchez, D Ceballos, Claudia Arajol, Pilar Robledo Andrés, Sabino Riestra, Ignacio Marín-Jiménez, Pilar Nos Mateu, S García-López

QUALITY OF LIFE IN ULCERATIVE COLITIS IS ALREADY IMPAIRED BY MILD DISEASE ACTIVITY CRONICA-UC STUDY

Julian Panés, Pilar Nos Mateu, Eugeni Domenech Morral, Ignacio Marín-Jiménez, Sabino Riestra, Javier Gisbert, Xavier Calvet Calvo, Oscar Rincon, Cristina Romero, Luis Cea-Calvo, Berta Juliá De Páramo

RAPIDITY OF ONSET OF RESPONSE TO ADALIMUMAB (ADA) IN LUMINAL CROHN´S DISEASE (CD). DATA FROM RAPIDA TRIAL

Ignacio Marín-Jiménez, Francesc Casellas, M Esteve, L Castro-Laria, S García-López, D Ceballos, A Echarri, MD Martín-Arranz, D Busquets, J Llaó, M Navarro-Llavat, JM Huguet, F Argüelles-Arias, R Vicente, L Rodríguez-San Pedro, G Díaz, R Casado, M Barreiro-de Acosta

RAPIDITY OF ONSET OF RESPONSE TO ADALIMUMAB (ADA) IN LUMINAL CROHN´S DISEASE (CD). DATA FROM RAPIDA TRIAL

Ignacio Marín-Jiménez

PREDICTING FACTORS OF PROXIMAL DISEASE EXTENT IN ULCERATIVE COLITIS IN THE BIOLOGIC ERA

Helena Martinez Lozano, Jose Luis Herrera Fajes, Julia García García, Ignacio Marín-Jiménez, Luis Menchén

SMOKING CESSATION AND THE COURSE OF CROHN'S DISEASE IN THE BIOLOGIC ERA: A MULTICENTER PROSPECTIVE STUDY

Tiago Nunes, María Josefina Etchevers, Carolina Figueroa, Valle García-Sánchez, Manuel Barreiro de Acosta, Ignacio Marín-Jiménez, Daniel Ginard Vicens, Eva Marti, Olga Merino, Sonia Gallego, Maite Arroyo, Esther García-Planella, Carme Loras Alastruey, Miquel Sans, Luis Menchén

COMPARISON OF ORIGINAL AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE AND MULTICENTRIC STUDY IN  SPAIN

Helena Martinez Lozano, Jose Miranda Bautista, keyla villa, Iago González Lama, Pilar López Serrano, José Lázaro Pérez-Calle, Pablo Pérez Galindo, Daniel Carpio López, VIRGINIA MATALLANA ROYO, Marta Calvo, Maria Isabel Vera, Ignacio Marín-Jiménez, Luis Menchén Viso

APPRECIA: ADALIMUMAB VS AZATHIOPRINE IN THE PREVENTION OF CROHN’S DISEASE RECURRENCE AFTER SURGICAL RESECTION. A GETECCU MULTICENTER RANDOMIZED TRIAL.

Antonio López San Román, Isabel Vera Mendoza, Eugeni Domenech Morral, Carlos Taxonera, Vicente Vega, Ignacio Marín-Jiménez, Jordi Guardiola Capon, Luisa Castro, Maria Esteve Comas, Valle García, Daniel Ceballos, Pilar Martínez-Montiel, Javier Gisbert, Miguel Mínguez, Ana Echarri Piudo, Xavier Calvet Calvo, Jesús Barrio, Jo

ENTERO-URINARY FISTULAS TREATED WITH ANTI-TNF: OUTCOMES AND PREDICTORS OF RESPONSE

Carlos Taxonera Samso, Manuel Barreiro de Acosta, Javier Martinez Gonzalez, Olga Merino, Valle García-Sánchez, Ignacio Marín-Jiménez, Maria Chaparro Sanchez, Jose Fernando Muñoz Nuñez, Fernando Bermejo, Leticia Pérez Carazo, Rocio Plaza, Juan L Mendoza, Javier Gisbert

Item 1 - 10 / 15
1
2
We use cookies in order to provide you with a better browsing experience. This includes third-party cookies for traffic analyzation purposes. See here for more information.
OK